Status:
UNKNOWN
Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Central Serous Chorioretinopathy
Eligibility:
All Genders
18+ years
Brief Summary
Objectives: 1. To conduct a Natural History Observation Study to characterize the clinical features and progression of Central Serous Chorioretinopathy (CSCR) from the earliest to the vision-threaten...
Detailed Description
Significance and Applications of Study Results: I) The proposed study will determine comprehensive clinical characterization of a large cohort of 350 CSCR patients with novel, non-invasive imaging te...
Eligibility Criteria
Inclusion
- Presence or evidence of prior serous retinal detachment documented on OCT involving the posterior pole unrelated to another disease process.
- At least 1 area of retinal pigment epithelium (RPE) alteration on FAF, SD-OCT, or infrared imaging.
- Subfoveal choroidal thickness (SFCT) of 300μm or more on SD enhanced depth imaging (EDI) OCT or SS-OCT for at least one eye.
- Patient 18 years or older.
- Willing to undergo pupil dilation, and protocol-required procedures for both eyes.
Exclusion
- Other maculopathy on clinical examination such as age-related macular degeneration (AMD).
- Media opacity such as cataract that could interfere with adequate acquisition of fundal images.
- Pregnant or nursing women.
Key Trial Info
Start Date :
March 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT05278169
Start Date
March 11 2022
End Date
December 31 2024
Last Update
August 30 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CUHK Eye Centre
Hong Kong, Hong Kong
2
Hong Kong Eye Hospital
Hong Kong, Hong Kong
3
Prince of Wales Hospital
Hong Kong, Hong Kong